IARS Appoints Dr. Michael Roizen as Chair of SAFEKIDS Anesthesia Safety Initiative

The International Anesthesia Research Society has announced that Michael F. Roizen, MD, will chair the Executive Board of SAFEKIDS (Safety of Key Inhaled and Intravenous Drugs in Pediatrics), a public-private partnership between the U.S. Food and Drug Administration and the IARS to address major gaps in scientific and clinical knowledge regarding safety for the millions of infants and children who undergo anesthesia and sedation each year, according to an IARS news release.

Advertisement

Projects conducted by SAFEKIDS will investigate aspects of existing anesthetics and their administration as well as patient outcomes in order to enhance the safety of current anesthetics and drive the development of new drugs, according to the release. The SAFEKIDS Executive Board and Dr. Roizen have announced a $30 million fundraising effort to support this research.

“Making sure that drugs, and procedures using drugs, are safe and have a good chance of benefiting a patient’s long-term health is the most important goal of medicine today,” Dr. Roizen said in the release. “The great news is that while anesthesia-related studies are difficult to do, the FDA and hundreds of researchers are enthusiastic about doing them. And we must do this work to make sure kids are cared for to the best of our abilities, and donating to this foundation is how the public can help. All monies collected — 100 percent of all donations — will be used to pursue these much-needed research studies.”

Read the IARS’s release on SAFEKIDS.

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.